References
- Matsuoka S., Huang M., Elledge S J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998; 282: 1893–1897
- Hirao A., Kong Y., Matsuoka S., Wakeham A., Ruland I., Yoshida H., Liu D., Uedge S. EJ, Mak T W. DMA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287: 1824–1827
- Brown A. L., Lee C. H., Schwarz J. K., Mitiku N., Piwnica-Worms H., Chung J H. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc Natl Acad Sci. USA 1999; 96: 3745–3750
- Chehab N. H., Malikzay A., Appel M., Halazonetis T D. Chk2/hCds1 functions as a DNA damage checkpoint in G(l) by stabilizing p53. Genes & Development 2000; 14: 278–288
- Bell D. W., Valery J. M., Szydlo T. E., Rang D. H., Wahrer D. C.R., Shannon K. E., Lubratovich M., Verseüs S. J., Isselbacher K. J., Fraumeni J. F., Birch J. M., Li F. P., Garber J. E., Haber D. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999; 286: 2528–2531
- Carr A M. Piecing together the p53 puzzle. Science 2000; 287: 1765–1767
- Shimoyama M., members of the Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol 1991; 79: 428–439, (1984-87)
- Jaffe E. S., Harris N. L., Diebold J., MuUer-Hermelink H K. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Am J Clin Pathol 1999; 111: S8–S12
- Sodha N., Williams R., Mangion J., Bullock S. L., Yuille M. R., Eeles R A. Screening hCHK2 for mutations. Science 2000; 298: 359
- Sakashita A., Hattori T., Miller C. M., Suzushima H., Asou N., Takatsuki K., Koeffler H P. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992; 79(2)477–480
- Imamura J., Miyoshi I., Koeffler H P. p53 in hematologic malignancies. Blood 1994; 84: 2412–2417
- Marks D. I., Kurz B. W., Link M. P., Ng E., Shuster J. J., Lauer S. J., Carrol D., Brodsky I., Haines D S. Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. J Clin Oncol 1997; 15: 1158–1162
- Uedge S.E. J., Mak T W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287: 1824–1827
- Ichikawa A., Kinoshita T., Watanabe T., Kato H., Nagai H., Tsushita K., Saito H., Hotta T. Mutations of the p53 gene as a prognostic factor in aggressive B-cell Lymphoma. The New England Journal of Medicine 1997; 337: 529–534
- Shiel S. Y., Ann J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes & Development 2000; 14: 289–300